Ces radiol. 2008, 62(1):82-85

-positive 99mTc-MIBI scintimammography in a patient with a granulomatous breast inflammationCase report

Jiří Doležal1, Hana Urminská-Klozová2
1 Oddělení nukleární medicíny LF UK a FN, Hradec Králové
2 Radiologická klinika LF UK a FN, Hradec Králové

To present a rare case report about a -positive 99mTc-MIBI scintimammography in a patient with a granulomatous breast inflammation. 55-years-old woman with positive history of eosinophilous leukaemia and the peripheral stem cells transplantation from HLA identical sister two years ago was examined for a few days persisting palpable breast mass (diameter 6 mm). There were no inflammation symptoms and no pain. The mammography and ultrasound were negative for malignant lesion. The woman underwent scintimammography with 99mTc-MIBI (740 MBq). There was detected a focus of increased uptake of 99mTc-MIBI in the right breast on the point of palpable mass. Scintimammography was very suspect for malignant lesion. The suspect palpable breast mass was removed surgically. The granulomatous breast inflammation was observed by histopathology. The scintimammography with 99mTc-MIBI was a positive for breast malignity. The positive uptake of tumour hot spot radiopharmaceutical 99mTc-MIBI was observed in granulomatous breast inflammation. The benefit of scintimammography in differential diagnostics of the breast inflammation and malignant lesion is controversial because the increased uptake of 99mTc-MIBI in both lesions was observed.

Keywords: 99mTc-MIBI, scintimammography, mastitis

Accepted: December 15, 2007; Published: March 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doležal J, Urminská-Klozová H. -positive 99mTc-MIBI scintimammography in a patient with a granulomatous breast inflammation. Ces radiol. 2008;62(1):82-85.
Download citation

References

  1. Thrall JH, Ziessman HA. Nuclear Medicine. St. Louis, Missouri: A Harcourt Health Sciences Company, Mosby Inc. 2001; 193-227.
  2. Hoefnagel CA. Nuclear medicine applications in oncology. Nuclear Medicine Review 1998; 1: 50-57.
  3. Mysliveček M, Koranda P, et al. Nukleární medicína v diagnostice nádorů a zánětů. Univerzita Palackého v Olomouci 2002; 14-21.
  4. Hušák V, Ptáček J, Mysliveček M, Kleinbauer K. Radiační zátěž a radiační ochrana pacienta v diagnostické nukleární medicíně. Praha: SÚJB 2004; 30.
  5. Pappo I, Horne T, Wessberg D, et al. The usefulness of MIBI scanning to detect underlying carcinoma in women with acute mastitis. Breast J 2000; 6: 126-129. Go to original source... Go to PubMed...
  6. Burak Z, Argon M, Memis A, et al. Evaluation of palpable breast masses with 99mTc-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994; 15: 604-612. Go to original source... Go to PubMed...
  7. Mysliveček M, Koranda P, Kamínek M, et al. Technetium-99m-MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involment. Nucl Med Rev cent East Eur 2004; 7: 151-155.
  8. Palmedo H, Biersack HJ, Lastoria S, et al. Scintimammography with technetium-99m-methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med 1998; 25: 375-385. Go to original source... Go to PubMed...
  9. Mekhmandarov S, Sandbank J, Cohen M, et al. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions. J Nucl Med 1998; 39: 86-91.
  10. Fenlon HM, Phelan NC, O'Sullivan P, et al. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. Radiology 1997; 205: 214-220. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.